StockData
Myriad Genetics Inc logo

Myriad Genetics Inc (MYGN) stock

MYGNNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 8/3070% below fair value
$5.54−0.03 (-0.54%)

Close on Nov 17, 2026Market cap $529.90MP/E –Yield –

Myriad Genetics gross margin

Gross margin is gross profit as a percentage of revenue.

Myriad Genetics's gross margin for the twelve months ending Jun 30, 2026 was 68.8%. For fiscal 2025 it was 69.9%, against 69.9% the year before. The highest annual figure on record is 89.6% in fiscal 2012.

Annual gross margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 202569.9%+0.0
FY2024Dec 31, 202469.9%+1.2
FY2023Dec 31, 202368.6%−1.6
FY2022Dec 31, 202270.2%−9.9
FY2017Jun 30, 201780.1%−2.0
FY2016Jun 30, 201682.1%+0.4
FY2015Jun 30, 201581.6%−6.0
FY2014Jun 30, 201487.7%−1.8
FY2013Jun 30, 201389.5%−0.1
FY2012Jun 30, 201289.6%+1.0
FY2011Jun 30, 201188.6%+0.9
FY2010Jun 30, 201087.8%+1.0
FY2009Jun 30, 200986.7%–

Quarterly gross margin

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange (pts)
Q2 FY2026CQ2 2026Jun 30, 202666.6%−4.6
Q1 FY2026CQ1 2026Mar 31, 202668.7%+0.2
Q4 FY2025CQ4 2025Dec 31, 202570.0%−1.7
Q3 FY2025CQ3 2025Sep 30, 202569.9%−0.3
Q2 FY2025CQ2 2025Jun 30, 202571.2%+1.7
Q1 FY2025CQ1 2025Mar 31, 202568.5%+0.5
Q4 FY2024CQ4 2024Dec 31, 202471.7%+3.0
Q3 FY2024CQ3 2024Sep 30, 202470.2%+0.2
Q2 FY2024CQ2 2024Jun 30, 202469.6%+1.0
Q1 FY2024CQ1 2024Mar 31, 202468.1%+0.7
Q4 FY2023CQ4 2023Dec 31, 202368.7%−1.0
Q3 FY2023CQ3 2023Sep 30, 202370.0%+2.2
Q2 FY2023CQ2 2023Jun 30, 202368.5%−3.8
Q1 FY2023CQ1 2023Mar 31, 202367.3%−3.6
Q4 FY2022CQ4 2022Dec 31, 202269.7%−10.2
Q3 FY2022CQ3 2022Sep 30, 202267.8%−12.2
Q2 FY2022CQ2 2022Jun 30, 202272.3%−7.5
Q1 FY2022CQ1 2022Mar 31, 202270.9%−11.2
Q3 FY2018CQ1 2018Mar 31, 201879.9%−0.6
Q2 FY2018CQ4 2017Dec 31, 201779.9%−1.1
Q1 FY2018CQ3 2017Sep 30, 201779.8%−1.1
Q4 FY2017CQ2 2017Jun 30, 201782.1%+1.9
Q3 FY2017CQ1 2017Mar 31, 201780.5%−1.8
Q2 FY2017CQ4 2016Dec 31, 201681.0%−1.4
Q1 FY2017CQ3 2016Sep 30, 201680.8%−2.3
Q4 FY2016CQ2 2016Jun 30, 201680.2%−2.9
Q3 FY2016CQ1 2016Mar 31, 201682.4%+0.7
Q2 FY2016CQ4 2015Dec 31, 201582.4%–
Q1 FY2016CQ3 2015Sep 30, 201583.2%–
Q4 FY2015CQ2 2015Jun 30, 201583.1%–
Q3 FY2015CQ1 2015Mar 31, 201581.7%–

More Myriad Genetics figures

See a number that looks wrong?